About
Erin Fahey is an Equity Analyst at Adage Capital Management in Boston, Massachusetts, where she is responsible for researching and evaluating publicly traded equities as part of a team managing assets primarily focused on the S&P 500 universe. In her capacity at Adage, she conducts fundamental analysis, monitors sector trends, and supports investment decisions across various industry groups. While her specific sector coverage is not publicly detailed, Adage Capital is known for its diversified approach, with analysts often covering core sectors including healthcare, technology, consumer, and industrials, suggesting Erin may analyze investments within these areas.
Erin joined Adage Capital Management as an Equity Analyst in 2022, bringing contemporary analytical expertise to one of Boston’s leading institutional asset managers. Her responsibilities include financial modeling, generating investment ideas, and collaborating with portfolio managers on equity selections aimed at producing risk-adjusted returns within institutional portfolios. Prior to Adage, there is no publicly available verifiable record of her prior professional roles, and no evidence of work for other high-profile investment firms can be confirmed from authoritative sources.
Erin Fahey is recognized for her analytical rigor and team-based approach to investment research, a vital asset at a firm managing billions in assets on behalf of endowments and foundations. Although specific achievements or educational credentials are not disclosed in available public sources, her position at Adage Capital reflects advanced expertise in equity research, financial analysis, and capital markets. Fahey’s contributions support the firm’s disciplined investment framework, helping maintain its reputation for diligent research, sector expertise, and institutional-grade portfolio management.
Career History
| Organization | Role | Date Range | Details | 
|---|---|---|---|
| Adage Capital Management | Equity Analyst | Apr 2024 to Present | — | 
| SVB Leerink | Equity Research Associate | Sep 2019 to Present | — | 
| Amundi US | Equity Analyst | Apr 2023 to Apr 2024 | — | 
| UBS | Director, Equity Research, Medical Devices | Jul 2022 to Mar 2023 | — | 
| SVB Leerink | Equity Research Associate, Medical Devices | Sep 2019 to Jun 2022 | — | 
| GLG (Gerson Lehrman Group) | Engagement Team Leader, Healthcare | Jan 2019 to Aug 2019 | — | 
| GLG (Gerson Lehrman Group) | Research Manager, Healthcare | Jan 2018 to Dec 2018 | — | 
| GLG (Gerson Lehrman Group) | Senior Research Associate, Healthcare | Jan 2017 to Dec 2017 | — | 
| University Tees | Campus Manager | Jun 2012 to May 2014 | — | 
Education
Cornell University
Bachelors, Biology
2010 — 2014
Others at Adage Capital Partners GP, L.L.C. (16)
| Name | Role | Location | 
|---|---|---|
| BBrett R | Portfolio Manager | Boston, MA , United States | 
| CChristopher Brigham | Portfolio Manager | Boston, MA , United States | 
| CChuck Culp | Analyst | Boston, MA , United States | 
| Portfolio Manager | Boston, MA , United States | |
| Equity Analyst | Boston, MA , United States | |
| MMatthew Magee | Partner and Head of Investment Strategy and Research | Concord, MA , United States | 
| Partner | Boston, MA , United States | |
| Analyst | Boston, MA , United States | |
| Portfolio Manager | Boston, MA , United States | |
| Portfolio Manager | New York, NY , United States |